Monoclonal antibodies have become indispensable in medicine to combat cancers, infectious diseases and autoimmune disorders.

Newer drugs under the microscope include J&J’s IL-12 and IL-23 inhibitor Stelara (ustekinumab) – approved for ulcerative colitis by the FDA less than a year ago – plus Takeda’s α4β7 ...

AbbVie has received European Commission approval of its anti-inflammation drug Skyrizi for the treatment of adult patients ...

There are several drugs a person with ulcerative colitis (UC) should avoid, as they may worsen symptoms. Examples include nonsteroidal anti-inflammatory drugs, some antibiotics, certain supplement ...

Lilly is already active in the area, winning US Food and Drug Administration approval last year for its Omvoh injection for ulcerative colitis. Pills like the one Morphic is developing could help ...

Learn more about the FDA-approved ulcerative colitis drugs @ Drugs for Ulcerative Colitis Treatment A few FDA-approved drugs for ulcerative colitis treatment include SIMPONI (Janssen ...

Takeda Pharmaceutical reported a rise in first-quarter net profit as revenue climbed, driven by sales growth of key drugs and a weaker yen. The Japanese drugmaker said Wednesday that net profit ...

Eli Lilly announced last year its medication Omvoh was approved by the Food and Drug Administration for treating adults with moderate-to-severe ulcerative colitis. Morphic has been developing its ...

Ciclosporin A (CyA) was the cornerstone of rescue medical therapy for steroid-refractory acute severe colitis until the advent ... prudence in the way the drug is administered and monitored ...

Investigators enrolled 136 people with moderate to severe active ulcerative colitis who were failed by existing drugs such as ...

2009;3(4):395-405. Similar to CyA, infliximab is not without potentially serious toxicity, including infections, lymphoma, drug-induced liver injury and demyelinating disease. However, data from ...